APA (7th ed.) Citation

Zhang, J., Zhao, C., Cheng, Y., Zhu, L., Song, Z., Xu, N., . . . Xu, J. (2023). Preliminary results of a phase I, first-in-human, dose escalation study of IMM2902 in patients with HER2-expressing advanced solid tumors. Journal of clinical oncology, 41(16_suppl), e15185. https://doi.org/10.1200/JCO.2023.41.16_suppl.e15185

Chicago Style (17th ed.) Citation

Zhang, Jian, et al. "Preliminary Results of a Phase I, First-in-human, Dose Escalation Study of IMM2902 in Patients with HER2-expressing Advanced Solid Tumors." Journal of Clinical Oncology 41, no. 16_suppl (2023): e15185. https://doi.org/10.1200/JCO.2023.41.16_suppl.e15185.

MLA (9th ed.) Citation

Zhang, Jian, et al. "Preliminary Results of a Phase I, First-in-human, Dose Escalation Study of IMM2902 in Patients with HER2-expressing Advanced Solid Tumors." Journal of Clinical Oncology, vol. 41, no. 16_suppl, 2023, p. e15185, https://doi.org/10.1200/JCO.2023.41.16_suppl.e15185.